【癌症】《Oregon》與《Lantern Pharma》聯手利用AI優化「癌症」代謝抑制劑的開發

 【癌症】《Oregon Therapeutics》與《Lantern Pharma》聯手利用AI優化「癌症」代謝抑制劑的開發

 文章出處  

Businesswire 

 

 原文標題  

Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 – A Potent Inhibitor of Cancer Metabolism 

 

 Twitter  

https://twitter.com/aimedadviser/status/1788335028847747087 

 

 文章序號  

5538 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.